News
Catalent acquires Oxfordshire facility to expand biologics in UK and Europe
Catalent has announced the acquisition from the Vaccine Manufacturing and Innovation Centre (VMIC) of a biologics development and manufacturing facility currently under construction near Oxford, UK.